|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.122 HKD | -12.86% |
|
-12.86% | -15.28% |
Wai Chun Bio-Technology Limited reported earnings results for the second half year ended June 30, 2022. For the second half year, the company reported sales was HKD 1,007.19 million. Net loss was HKD 23.53 million.
Basic loss per share from continuing operations was HKD 0.014. Diluted loss per share from continuing operations was HKD 0.014.
| 1st Jan change | Capi. | |
|---|---|---|
| -15.28% | 2.68M | |
| -11.53% | 3.9B | |
| +12.25% | 1.83B | |
| -4.30% | 683M | |
| -21.50% | 421M | |
| -81.65% | 216M | |
| -18.97% | 104M | |
| -6.88% | 58.11M |
WAI CHUN BIO-TECHNOLOGY LIMITED 
